Recent Broad Publications
- Hopping between Differentiation States in Lung Adenocarcinoma.
Read More / View Supplemental Materials - Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system.
Read More / View Supplemental Materials - The Genome of Anopheles darlingi, the main neotropical malaria vector.
Read More / View Supplemental Materials - ATHLATES: accurate typing of human leukocyte antigen through exome sequencing.
Read More / View Supplemental Materials - Integrated proteomic analysis of post-translational modifications by serial enrichment.
Read More / View Supplemental Materials
Scientific Publications
< Back to Publications
Identification of the molecular target of small molecule inhibitors of HDL receptor SR-BI activity.
| Publication Type | Journal Article |
| Authors | Nieland, TJ, Shaw JT, Jaipuri FA, Duffner JL, Koehler AN, Banakos S., Zannis VI, Kirchhausen T., and Krieger M. |
| Abstract | Scavenger receptor, class B, type I (SR-BI), controls high-density lipoprotein (HDL) metabolism by mediating cellular selective uptake of lipids from HDL without the concomitant degradation of the lipoprotein particle. We previously identified in a high-throughput chemical screen of intact cells five compounds (BLT-1-5) that inhibit SR-BI-dependent lipid transport from HDL, but do not block HDL binding to SR-BI on the cell surface. Although these BLTs are widely used to examine the diverse functions of SR-BI, their direct target(s), SR-BI itself or some other component of the SR-BI pathway, has not been identified. Here we show that SR-BI in the context of a membrane lipid environment is the target of BLT-1, -3, -4, and -5. The analysis using intact cells and an in vitro system of purified SR-BI reconstituted into liposomes was aided by information derived from structure-activity relationship (SAR) analysis of the most potent of these BLTs, the thiosemicarbazone BLT-1. We found that the sulfur atom of BLT-1 was crucially important for its inhibitory activity, because changing it to an oxygen atom resulted in the isostructural, but essentially inactive, semicarbazone derivative BLT-1sc. SAR analysis also established the importance of BLT-1's hydrophobic tail. BLTs and their corresponding inactive compounds can be used to explore the mechanism and function of SR-BI-mediated selective lipid uptake in diverse mammalian experimental models. Consequently, BLTs may help determine the therapeutic potential of SR-BI-targeted pharmaceutical drugs. |
| Year of Publication | 2008 |
| Journal | Biochemistry |
| Volume | 47 |
| Issue | 1 |
| Pages | 460-72 |
| Date Published (YYYY/MM/DD) | 2008/01/08 |
| ISSN Number | 0006-2960 |
| DOI | 10.1021/bi701277x |
| PubMed | http://www.ncbi.nlm.nih.gov/pubmed/18067275?dopt=Abstract |
Share This
- Tweet
